Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane

Ravi Kumar, Tristan De Mooij, Timothy E. Peterson, Tatiana Kaptzan, Aaron J. Johnson, David Daniels, Ian F Parney

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14+ monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloidderived suppressor cells when normal monocytes are exposed to glioma conditioned media.

Original languageEnglish (US)
Article numbere0179012
JournalPLoS One
Volume12
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

suppressor cells
Conditioned Culture Medium
Glioma
Macrophage Migration-Inhibitory Factors
Monocytes
monocytes
Glioblastoma
Dendritic Cells
dendritic cells
T-cells
Flow cytometry
Confocal microscopy
Cell proliferation
Immunosuppressive Agents
Interleukin-8
Cell culture
Tumors
Interleukin-6
Brain
immunosuppression

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane. / Kumar, Ravi; De Mooij, Tristan; Peterson, Timothy E.; Kaptzan, Tatiana; Johnson, Aaron J.; Daniels, David; Parney, Ian F.

In: PLoS One, Vol. 12, No. 6, e0179012, 01.06.2017.

Research output: Contribution to journalArticle

Kumar, Ravi ; De Mooij, Tristan ; Peterson, Timothy E. ; Kaptzan, Tatiana ; Johnson, Aaron J. ; Daniels, David ; Parney, Ian F. / Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane. In: PLoS One. 2017 ; Vol. 12, No. 6.
@article{bd1b80b255154a99a5009d44770d2ed8,
title = "Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane",
abstract = "Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14+ monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloidderived suppressor cells when normal monocytes are exposed to glioma conditioned media.",
author = "Ravi Kumar and {De Mooij}, Tristan and Peterson, {Timothy E.} and Tatiana Kaptzan and Johnson, {Aaron J.} and David Daniels and Parney, {Ian F}",
year = "2017",
month = "6",
day = "1",
doi = "10.1371/journal.pone.0179012",
language = "English (US)",
volume = "12",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane

AU - Kumar, Ravi

AU - De Mooij, Tristan

AU - Peterson, Timothy E.

AU - Kaptzan, Tatiana

AU - Johnson, Aaron J.

AU - Daniels, David

AU - Parney, Ian F

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14+ monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloidderived suppressor cells when normal monocytes are exposed to glioma conditioned media.

AB - Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression. Understanding mechanisms of MDSC formation and function are key to developing effective immunotherapies. In this study, we developed a novel model to reliably generate human MDSCs from healthy-donor CD14+ monocytes by culture in human glioma-conditioned media. Monocytic MDSC frequency was assessed by flow cytometry and confocal microscopy. The resulting MDSCs robustly inhibited T cell proliferation. A cytokine array identified multiple components of the GCM potentially contributing to MDSC generation, including Monocyte Chemoattractive Protein-1, interleukin-6, interleukin-8, and Macrophage Migration Inhibitory Factor (MIF). Of these, Macrophage Migration Inhibitory Factor is a particularly attractive therapeutic target as sulforaphane, a naturally occurring MIF inhibitor derived from broccoli sprouts, has excellent oral bioavailability. Sulforaphane inhibits the transformation of normal monocytes to MDSCs by glioma-conditioned media in vitro at pharmacologically relevant concentrations that are non-toxic to normal leukocytes. This is associated with a corresponding increase in mature dendritic cells. Interestingly, sulforaphane treatment had similar pro-inflammatory effects on normal monocytes in fresh media but specifically increased immature dendritic cells. Thus, we have used a simple in vitro model system to identify a novel contributor to glioblastoma immunosuppression for which a natural inhibitor exists that increases mature dendritic cell development at the expense of myeloidderived suppressor cells when normal monocytes are exposed to glioma conditioned media.

UR - http://www.scopus.com/inward/record.url?scp=85021693126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021693126&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0179012

DO - 10.1371/journal.pone.0179012

M3 - Article

C2 - 28666020

AN - SCOPUS:85021693126

VL - 12

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e0179012

ER -